immatics biotechnology GmbH
Records under this name other than patents immatics biotechnology GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to immatics biotechnology GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,155,801 | Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors Held by another company In force · High confidence | In force | High confidence | |
| US 11,939,376 | Novel T Cell Receptors and Immune Therapy Using the Same Held by another company In force · High confidence | In force | High confidence | |
| US 10,000,547 | Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors Held by another company Lapsed on the fee record Ended Jun 19, 2026 · High confidence | Lapsed on the fee record | Ended Jun 19, 2026 | High confidence |